Marken's Ariette van Strien on Facing the Future of the Biotherapeutics Supply Chain

In this interview Ariette van Strien, SVP Commercial Operation, Marken, speaks to Andrea Charles from Cold Chain IQ, about biologics taking over and the changing paradigm the supply chain, rethinking getting drugs into the global arena and optimising the supply globally. She also shares her insights on the implications of higher value products in the supply chain. To continue reading this story Click Here